Skip to main content
. 2023 Apr 8;28(8):3318. doi: 10.3390/molecules28083318

Figure 5.

Figure 5

Cell viability (% of that of untreated cells) 48 h after treatment with CPP, CPP-AuNP, siRNA/CPP, siRNA/CPP-AuNP, and siRNA/LF 2000 in: (a) serum-free medium (Opti-MEM) and (b) serum-containing medium (DMEM/F-12). The doses indicate: for CPP treatment—added CPP mass, in other cases—added AuNPs mass. For statistical analysis, see Tables S3 and S4.